DENTSPLY SIRONA's (XRAY) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) in a report released on Tuesday,Benzinga reports. Needham & Company LLC currently has a $25.00 price objective on the medical instruments supplier's stock.

XRAY has been the topic of a number of other reports. Leerink Partnrs cut DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research report on Thursday, November 7th. Barrington Research decreased their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating on the stock in a research report on Friday, November 8th. Evercore ISI reissued an "in-line" rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their target price for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Finally, StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, February 7th. Ten investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $25.85.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock traded down $0.45 during midday trading on Tuesday, hitting $18.32. The company had a trading volume of 2,580,852 shares, compared to its average volume of 2,164,900. The business's 50 day simple moving average is $19.02 and its two-hundred day simple moving average is $21.96. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $34.91. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a market cap of $3.64 billion, a PE ratio of -8.85, a P/E/G ratio of 1.83 and a beta of 0.96.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.49%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA's dividend payout ratio is presently -30.92%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. State of Alaska Department of Revenue raised its stake in DENTSPLY SIRONA by 2.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier's stock worth $637,000 after purchasing an additional 560 shares in the last quarter. Treasurer of the State of North Carolina increased its holdings in shares of DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock worth $1,686,000 after purchasing an additional 560 shares during the period. UMB Bank n.a. raised its position in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 564 shares in the last quarter. MML Investors Services LLC boosted its stake in shares of DENTSPLY SIRONA by 2.1% in the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier's stock valued at $803,000 after buying an additional 620 shares during the period. Finally, Allworth Financial LP increased its stake in DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier's stock worth $59,000 after acquiring an additional 625 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.